Novarad develops new extensive integration with PowerScribe® 360

Published on:

SALT LAKE CITY—Utah-based healthcare technology company Novarad’s most recent software development has enabled the company to achieve deep integration between its Picture Archiving and Communication System (PACS) and Nuance’s PowerScribe 360 dictation software.

Inconveniences in dictation throughout the healthcare industry include the repetitive and often time-consuming opening and closing of separate programs, the doubt as to whether or not a study has been updated correctly, and the discrepancies in communication between whichever programs you choose to use for imaging and for dictation.

“We are one of a small handful of PACS vendors that have completed this kind of integration,” said David GrandPre, Director of Implementation at Novarad.

This integration allows healthcare professionals to run NovaPACS or PowerScribe from either program. It also includes auto-launching of PowerScribe when signing into PACS, the ability to park a dictation when using PowerScribe, and the seamless communication of study information and status between the two systems.

To learn more about Novarad or the recent integration, follow the company on Twitter, @NovaradCorp, or visit their website, www.novarad.net.

Related Content

FDA clears AI-assisted CCTA software that assesses plaques for signs of heart disease
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension
Building a successful CCTA program: Physicians and healthcare executives to share advice
How AI and CCTA help heart teams plan ahead before PCI
Cardiologists recommend complete revascularization, intravascular imaging in new ACS guidelines
Why cardiac CT adoption remains low among primary care providers

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.